23 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
significantly harm our reputation and business prospects.
Serious adverse events, undesirable side effects or other unexpected properties of our current … ;
we could be sued and held liable for harm caused to patients; and
our reputation may suffer.
If any of our product candidates are associated
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
interim or preliminary or topline data and final data could significantly harm our reputation and business prospects.
Serious adverse events, undesirable … outlining the risks of such side effects for distribution to patients;
we could be sued and held liable for harm caused to patients; and
our reputation may
DRS
EX-10.21
q5254anm8ag03tp1
28 Jan 21
Draft registration statement
12:00am
DRS
6b7qc q3h
28 Jan 21
Draft registration statement
12:00am
10-Q
x09lf m4zo8k
12 Nov 20
Quarterly report
8:01am
424B4
0aeyoau3
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
rbj1 8fcqoel8wvqvl
11 Sep 20
IPO registration
4:49pm
S-1
EX-10.10
1atu9doo09 b4x69ktdf
11 Sep 20
IPO registration
4:49pm
S-1
EX-10.16
rn7qevs cv1as54821l5
11 Sep 20
IPO registration
4:49pm
S-1
EX-10.19
l6jrw
11 Sep 20
IPO registration
4:49pm
DRS/A
yvs4ewoprggeiohs4nmj
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
7co9hm5nlq
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
yzc8o78 9y
20 Dec 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.19
b7bxzj2m s41e9r4
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
zzkjf
31 Oct 19
Draft registration statement
12:00am